Nat Rev Cancer. 2007 Feb;7(2):131-9.

Compressing drug development timelines in oncology using phase '0' trials.

Kummar S, Kinders R, Rubinstein L, Parchment RE, Murgo AJ, Collins J, Pickeral O, Low J, Steinberg SM, Gutierrez M, Yang S, Helman L, Wiltrout R, Tomaszewski JE, Doroshow JH.

Source

Center for Cancer Research, SAIC-Frederick, Inc., NCI-Frederick, Frederick, Maryland, USA.

Abstract

The optimal evaluation of molecularly targeted anticancer agents requires the integration of pharmacodynamic assays into early clinical investigations. Phase '0' trials conducted under the new Exploratory Investigational New Drug Guidance from the US Food and Drug Administration can provide a platform to establish the feasibility of assays for target modulation in human samples, evaluate biomarkers for drug effects and provide pharmacokinetic data. Phase 0 trials could facilitate rational drug selection, identify therapeutic failures early, and might compress timelines for anticancer drug development. We expect that such trials will become a routine part of early-phase oncological drug development in the future.

PMID:: 17251919; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

Antineoplastic Agents

LinkOut - more resources

Full Text Sources

Medical

Supplemental Content

Related citations

Review Phase 0 clinical trials in cancer drug development: from FDA guidance to clinical practice. [Mol Interv. 2007]
Review Phase 0 clinical trials in cancer drug development: from FDA guidance to clinical practice.
Kinders R, Parchment RE, Ji J, Kummar S, Murgo AJ, Gutierrez M, Collins J, Rubinstein L, Pickeral O, Steinberg SM, et al. Mol Interv. 2007 Dec; 7(6):325-34.
Phase 0 clinical trials will overcome stagnation of anticancer drug development? [Klin Onkol. 2011]
Phase 0 clinical trials will overcome stagnation of anticancer drug development?
Mendoza L. Klin Onkol. 2011; 24(2):143-5.
Oncologic phase 0 trials incorporating clinical pharmacodynamics: from concept to patient. [Clin Cancer Res. 2008]
Oncologic phase 0 trials incorporating clinical pharmacodynamics: from concept to patient.
Doroshow JH, Parchment RE. Clin Cancer Res. 2008 Jun 15; 14(12):3658-63.
Review Phase 0 clinical trials in oncology: a paradigm shift for early drug development? [Cancer Chemother Pharmacol. 2009]
Review Phase 0 clinical trials in oncology: a paradigm shift for early drug development?
Takimoto CH. Cancer Chemother Pharmacol. 2009 Mar; 63(4):703-9. Epub 2008 Jul 10.
Review Biomarker-driven early clinical trials in oncology: a paradigm shift in drug development. [Cancer J. 2009]
Review Biomarker-driven early clinical trials in oncology: a paradigm shift in drug development.
Tan DS, Thomas GV, Garrett MD, Banerji U, de Bono JS, Kaye SB, Workman P. Cancer J. 2009 Sep-Oct; 15(5):406-20.

See reviews... See all...

Cited by 21 PubMed Central articles

Phase 0 Workshop at the 20th EORTC-NCI-AACR Symposium, Geneva. [Ecancermedicalscience. 2008]
Phase 0 Workshop at the 20th EORTC-NCI-AACR Symposium, Geneva.
Camporesi S. Ecancermedicalscience. 2008; 2:107. Epub 2008 Nov 12.
Modeling pharmacodynamic response to the poly(ADP-Ribose) polymerase inhibitor ABT-888 in human peripheral blood mononuclear cells. [PLoS One. 2011]
Modeling pharmacodynamic response to the poly(ADP-Ribose) polymerase inhibitor ABT-888 in human peripheral blood mononuclear cells.
Ji J, Kinders RJ, Zhang Y, Rubinstein L, Kummar S, Parchment RE, Tomaszewski JE, Doroshow JH. PLoS One. 2011; 6(10):e26152. Epub 2011 Oct 10.
Phase 0 clinical trials in oncology new drug development. [Perspect Clin Res. 2011]
Phase 0 clinical trials in oncology new drug development.
Gupta UC, Bhatia S, Garg A, Sharma A, Choudhary V. Perspect Clin Res. 2011 Jan; 2(1):13-22.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Compressing drug development timelines in oncology using phase '0' trials.
Compressing drug development timelines in oncology using phase '0' trials.
Nat Rev Cancer. 2007 Feb ;7(2):131-9.

PubMed
Rapid rehabilitation in elderly patients after laparoscopic colonic resection.
Rapid rehabilitation in elderly patients after laparoscopic colonic resection.
Br J Surg. 2000 Nov ;87(11):1540-5.

PubMed
Molecular and genetic characterization of the TonB2-cluster TtpC protein in path...
Molecular and genetic characterization of the TonB2-cluster TtpC protein in pathogenic vibrios.
Biometals. 2009 Feb ;22(1):109-15. Epub 2009 Jan 8 .

PubMed
Short- and long-term safety of weekly high-dose vitamin D3 supplementation in sc...
Short- and long-term safety of weekly high-dose vitamin D3 supplementation in school children.
J Clin Endocrinol Metab. 2008 Jul ;93(7):2693-701. Epub 2008 Apr 29 .

PubMed
A phase I trial of an interleukin-12/23 monoclonal antibody in relapsing multipl...
A phase I trial of an interleukin-12/23 monoclonal antibody in relapsing multiple sclerosis.
Curr Med Res Opin. 2006 Sep ;22(9):1671-8.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: